Capital International Investors 13D/13G Filings for Quince Therapeutics, Inc. (QNCX)

Capital International Investors 13D and 13G filings for Quince Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-12-10
4:09 pm
Unchanged
2021-12-1013GQUINCE THERAPEUTICS, INC
QNCX
Capital International Investors7,312
4.900%
0
(Unchanged)
Filing
2021-12-10
2:34 pm
Sale
2021-12-1013GQUINCE THERAPEUTICS, INC
QNCX
Capital International Investors7,312
4.900%
-7,570decrease
(-50.87%)
Filing
2021-10-08
12:10 pm
Unchanged
2021-10-1213GQUINCE THERAPEUTICS, INC
QNCX
Capital International Investors14,882
10.000%
0
(Unchanged)
Filing
2021-10-08
12:03 pm
Purchase
2021-10-1213GQUINCE THERAPEUTICS, INC
QNCX
Capital International Investors14,882
10.000%
1,980increase
(+15.35%)
Filing